Literature DB >> 7822182

Skull base chondroma of extracranial origin.

J Y Sichel1, J P Monteil, J Elidan.   

Abstract

METHODS: Two cases of chondroma at the skull base, most probably of extracranial origin, are presented: one at the apex of the petrous pyramid and the other in the infratemporal fossa.
RESULTS: In the second case, the surgical findings suggested that the tumor originated in the cartilagineous part of the eustachian tube. The world literature was reviewed and only three cases of extracranial chondromas at the skull base, and ten cases of chondromas of the nasopharynx have been described so far.
CONCLUSIONS: The potential origins of chondromas at the skull base are discussed: Cartilagineous remnants at the basisphenoid and basiocciput or the cartilagineous part of the eustachian tube seem to be the most probable origin.

Entities:  

Mesh:

Year:  1994        PMID: 7822182     DOI: 10.1002/hed.2880160614

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

Review 1.  Primary tumors and tumor-like lesions of the eustachian tube: a systematic review of an emerging entity.

Authors:  Enrico Muzzi; Elona Cama; Paolo Boscolo-Rizzo; Franco Trabalzini; Edoardo Arslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-09       Impact factor: 2.503

2.  Surgical Strategies and Outcomes for Intracranial Chondromas: A Retrospective Study of 17 Cases and Systematic Review.

Authors:  Hongyuan Liu; Qing Cai; Junting Li; Yafei Xue; Yunze Zhang; Zongping Li; Tianzhi Zhao; Yingxi Wu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

3.  Osseous hamartoma arising from the eustachian tube.

Authors:  Ai Kawamoto; Yukio Katori; Yohei Honkura; Masaki Ogura; Takeshi Oshima; Toshimitsu Kobayashi
Journal:  Clin Pract       Date:  2013-09-09

4.  Intra-cranial Chondroma: A Case Report and Problematic Diagnosis.

Authors:  Arezoo Eftekhar Javadi; Elham Nazar; Hedieh Moradi Tabriz
Journal:  Iran J Pathol       Date:  2020-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.